SCHEMBL30903282

CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O

nearest known ligand 0.69

Predicted protein targets (top 13)

	gene	UniProt	supporting neighbours	confidence
▸	KDM1A	O60341	3/20	0.69

▸	MAPK8	P45983	1/20	0.64

▸	MAPK9	P45984	1/20	0.64

▸	MAPK10	P53779	1/20	0.64

▸	MAOB	P27338	1/20	0.63

▸	KDM5A	P29375	1/20	0.63

▸	KDM1B	Q8NB78	1/20	0.63

▸	NPY2R	P49146	7/20	0.61

▸	NPY4R	P50391	7/20	0.61

▸	NPY5R	Q15761	7/20	0.61

▸	NPY1R	P25929	5/20	0.61

▸	TFPI	P10646	5/20	0.60

▸	EPHA2	P29317	1/20	0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29811066	0.94	KDM1A (0.69)	KDM1AMAPK8MAPK9MAPK10MAOB
SCHEMBL29492018	0.92	KDM1A (0.66)	KDM1AMAPK8MAPK9MAPK10MAOB
SCHEMBL30262210	0.91	KDM1A (0.74)	KDM1AMAPK8MAPK9MAPK10MAOB
SCHEMBL30844313	0.88	KDM1A (0.67)	KDM1AMAPK8MAPK9MAPK10MAOB
SCHEMBL31182520	0.88	KDM1A (0.67)	KDM1AMAPK8MAPK9MAPK10MAOB
SCHEMBL30495769	0.88	MAPK8 (0.69)	KDM1AMAPK8MAPK9MAPK10NPY2R
SCHEMBL30834205	0.88	NPY2R (0.66)	KDM1ANPY2RNPY4RNPY5RNPY1R
SCHEMBL31276157	0.88	KDM1A (0.63)	KDM1AMAPK8MAPK9MAPK10MAOB
SCHEMBL30903267	0.87	NPY2R (0.59)	NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL29461492	0.87	NPY2R (0.64)	KDM1AMAOBKDM5AKDM1BNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240148849-A1	IMMUNOGENIC COMPOSITION, USE AND METHODS	GLAXOSMITHKLINE BIOLOGICALS SA (BE)	2024-05-09	—	—	US	disclosed